| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0005516> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0008963> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0013125> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0086589> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0162488> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0162489> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0162490> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0162491> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0162492> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0206015> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0206193> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0206194> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0919747> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C0948245> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C1698754> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/32515499_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.\', \'Infectious Diseases Unit, Department of Medicine (DAME), ASUFC, Udine, Italy.\', \'Institute of Clinical Pathology, Department of Medicine (DAME), ASUFC, Udine, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/De_Vita_Salvatore> <https://research.tib.eu/covid-19/entity/Fabris_Martina> <https://research.tib.eu/covid-19/entity/Pecori_Davide> <https://research.tib.eu/covid-19/entity/Peghin_Maddalena> <https://research.tib.eu/covid-19/entity/Quartuccio_Luca> <https://research.tib.eu/covid-19/entity/Sonaglia_Arianna> <https://research.tib.eu/covid-19/entity/Tascini_Carlo>
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/jmv.26149>
?:doi	10.1002/jmv.26149
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Journal of medical virology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32515499>
?:pmid	<https://research.tib.eu/covid-19/entity/32515499>
?:pmid	32515499
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.978
?:rankingScore_hIndex	105
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0021760_PREDISPOSES_C0032285> <https://research.tib.eu/covid-19/entity/C0206194_LOCATION_OF_C1609165> <https://research.tib.eu/covid-19/entity/C1609165_PREDISPOSES_C0032285>
?:title	Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32515499>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32515499>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all